Leonardo Roever Shares a Study on Eligibility Criteria for Endovascular Thrombectomy
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn:
”Endovascular Thrombectomy for Acute Stroke: Evolving Eligibility Criteria and Adjuvant Therapies
In this review, the authors present recent developments, highlighting how biological targets align with the pathophysiological chronology of primary and secondary injury after an ischemic stroke.
It also discusses why some clinical trials have demonstrated success and others may not, and proposes important considerations for the planning of future trials.
This synthesis aims to inform about the evolving evidence for the treatment of acute ischemic stroke and inspire the planning of clinical trials and next-generation therapies.
See the article.
Follow me for more content on evidence, management, and innovation in healthcare!”
Read the full article here.
Article: Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies
Authors: Martina Glavan, Jia Liu, Gisele Sampaio Silva, Thanh N Nguyen, Jiangbing Zhou, Nenad Sestan et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029